This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Florence Brunel, PhD
Senior Principal Scientist at Novo Nordisk


Florence was born and raised in France. She obtained a MS from the Ecole Nationale Superieure de Chimie De Montpellier, and then moved to the US. She obtained her Ph.D. with Prof. Arno Spatola at the University of Louisville, where her love of and career in peptides started. She then moved to San Diego to pursue her postdoctoral training with Dr. Phil Dawson at Scripps Research where she continued working with peptides while learning new methodologies such as chemical ligation. Florence then took her interest in turning peptides into drugs to the biotech and pharmaceutical industry at companies like Amylin Pharmaceuticals, Pfizer/CovX and Vertex Pharmaceuticals. Florence is now an employee of Novo Nordisk where her role has evolved into a strategy & portfolio position reviewing new technologies, project prioritization and external collaborations to meet Novo Nordisk’s strategy. Florence remains very active in the peptide community as an elected council member for the American Peptide Society, a board member for TIDES and the elected chair of the 2026 Chemistry and Biology of Peptides Gordon Research Conference.

Agenda Sessions

  • Chairman’s Remarks: Peptides for Cardio-Metabolic Disorders